Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959503 · ClinicalTrials.gov registry record · NA
Progel Vascular Sealant
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT01959503 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 158 participants.
The verdict
NCT01959503, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the safety and effectiveness of the Progel Vascular Sealant for use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.
Interventions
- DEVICE Progel Vascular Sealant
- DEVICE Gelfoam Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01959503
The ClinicalTrials.gov registry entry for NCT01959503 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Progel Vascular Sealant is the first listed.
NCT01959503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01959503 about?
NCT01959503 is a clinical study titled "Progel Vascular Sealant". This study is being conducted to evaluate the safety and effectiveness of the Progel Vascular Sealant for use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.
What is the current status of trial NCT01959503?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2013-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01959503?
The interventions under investigation include: Progel Vascular Sealant (DEVICE), Gelfoam Plus (DEVICE).
Who is sponsoring clinical trial NCT01959503?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.